BIOMAT Database Logo BIOMAT Database Logo

Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. 1983

A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010430 Pentosyltransferases Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
D005467 Floxuridine An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. FUdR,Fluorodeoxyuridine,5-FUdR,5-Fluorodeoxyuridine,5 Fluorodeoxyuridine
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013939 Thymidine Phosphorylase An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine. PD-ECGF,Platelet-Derived Endothelial Cell Growth Factor,Gliostatin,Platelet Derived Endothelial Cell Growth Factor

Related Publications

A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
Enzyme-prodrug systems: thymidine phosphorylase/5'-deoxy-5-fluorouridine.
January 2004, Methods in molecular medicine,
A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
Interferon-α enhances 5'-deoxy-5-fluorouridine-induced apoptosis by ERK-dependant upregulation of thymidine phosphorylase.
January 2013, BioMed research international,
A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
Thymidine phosphorylase expressed in macrophages enhances antitumor effect of 5'-deoxy-5-fluorouridine on human colorectal carcinoma cells.
January 2003, Anticancer research,
A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
[Effect of thymidine phosphorylase cDNA transfection on the inhibition of human colon carcinoma cell line by 5'-deoxy-5-fluorouridine].
April 2013, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery,
A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
Enhancement of the anti-tumor effect of 5'-deoxy-5-fluorouridine by transfection of thymidine phosphorylase gene into human colon cancer cells.
April 1999, Japanese journal of cancer research : Gann,
A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
Cytotoxic activity of 5'-deoxy-5-fluorouridine in cultured human tumors.
June 1983, Cancer treatment reports,
A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase.
August 1999, British journal of cancer,
A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
[Thymidine phosphorylase expressed in monocyte-macrophages enhanced anticancer effect of 5'-deoxy-5-fluorouridine on colorectal carcinoma cells].
May 2004, Zhonghua yi xue za zhi,
A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.
January 1993, Cancer chemotherapy and pharmacology,
A Kono, and Y Hara, and S Sugata, and Y Karube, and Y Matsushima, and H Ishitsuka
Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
September 1999, International journal of cancer,
Copied contents to your clipboard!